Instability of personal human metabotype is linked to all-cause mortality
Open Access
- 28 June 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 9810
Abstract
Disruption of metabolic homeostasis is an important factor in many diseases. Various metabolites have been linked to higher risk of morbidity and all-cause mortality using metabolomics in large population-based cohorts. In these studies, baseline metabolite levels were compared across subjects to identify associations with health outcomes, implying the existence of ‘healthy’ concentration ranges that are equally applicable to all individuals. Here, we focused on intra-individual changes in metabolite levels over time and their link to mortality, potentially allowing more personalized risk assessment. We analysed targeted metabolomics data for 134 blood metabolites from 1409 participants in the population-based CARLA cohort at baseline and after four years. Metabotypes of the majority of participants (59%) were extremely stable over time indicated by high correlation between the subjects’ metabolite profiles at the two time points. Metabotype instability and, in particular, decrease of valine were associated with higher risk of all-cause mortality in 7.9 years of follow-up (hazard ratio (HR) = 1.5(95%CI = 1.0–2.3) and 0.2(95%CI = 0.1–0.3)) after multifactorial adjustment. Excluding deaths that occurred in the first year after metabolite profiling showed similar results (HR = 1.8(95%CI = 1.1–2.8)). Lower metabotype stability was also associated with incident cardiovascular disease (OR = 1.2(95%CI = 1.0–1.3)). Therefore, changes in the personal metabotype might be a valuable indicator of pre-clinical disease.Keywords
This publication has 33 references indexed in Scilit:
- Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic ReviewJournal of the American Heart Association, 2017
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- A wellness study of 108 individuals using personal, dense, dynamic data cloudsNature Biotechnology, 2017
- Associations Between the Serum Metabolome and All-Cause Mortality Among African Americans in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Epidemiology, 2016
- Metabolomics in the developmental origins of obesity and its cardiometabolic consequencesJournal of Developmental Origins of Health and Disease, 2015
- A metabolomic profile is associated with the risk of incident coronary heart diseaseAmerican Heart Journal, 2014
- Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 PersonsPLOS Medicine, 2014
- Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery diseaseAmerican Heart Journal, 2012
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular EventsCirculation: Cardiovascular Genetics, 2010